160 related articles for article (PubMed ID: 23615270)
1. Topical drug formulations for prolonged corneal anesthesia.
Wang L; Shankarappa SA; Tong R; Ciolino JB; Tsui JH; Chiang HH; Kohane DS
Cornea; 2013 Jul; 32(7):1040-5. PubMed ID: 23615270
[TBL] [Abstract][Full Text] [Related]
2. Corneal Anesthesia With Site 1 Sodium Channel Blockers and Dexmedetomidine.
McAlvin JB; Zhan C; Dohlman JC; Kolovou PE; Salvador-Culla B; Kohane DS
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):3820-6. PubMed ID: 26066750
[TBL] [Abstract][Full Text] [Related]
3. Tetrodotoxin, Epinephrine, and Chemical Permeation Enhancer Combinations in Peripheral Nerve Blockade.
Santamaria CM; Zhan C; McAlvin JB; Zurakowski D; Kohane DS
Anesth Analg; 2017 Jun; 124(6):1804-1812. PubMed ID: 28452816
[TBL] [Abstract][Full Text] [Related]
4. Experimental use of tetrodotoxin for corneal pain after excimer laser keratectomy.
Schwartz DM; Duncan KG; Duncan JL
Cornea; 1998 Mar; 17(2):196-9. PubMed ID: 9520198
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of duration of corneal anesthesia induced with ophthalmic 0.5% proparacaine hydrochloride by use of a Cochet-Bonnet aesthesiometer in clinically normal horses.
Kalf KL; Utter ME; Wotman KL
Am J Vet Res; 2008 Dec; 69(12):1655-8. PubMed ID: 19046014
[TBL] [Abstract][Full Text] [Related]
6. Duration of corneal anesthesia following topical administration of 0.5% proparacaine hydrochloride solution in clinically normal cats.
Binder DR; Herring IP
Am J Vet Res; 2006 Oct; 67(10):1780-2. PubMed ID: 17014333
[TBL] [Abstract][Full Text] [Related]
7. Tetrodotoxin: anesthetic activity in the de-epithelialized cornea.
Schwartz DM; Duncan KG; Fields HL; Jones MR
Graefes Arch Clin Exp Ophthalmol; 1998 Oct; 236(10):790-4. PubMed ID: 9801896
[TBL] [Abstract][Full Text] [Related]
8. Long-acting liposomal corneal anesthetics.
Zhan C; Santamaria CM; Wang W; McAlvin JB; Kohane DS
Biomaterials; 2018 Oct; 181():372-377. PubMed ID: 30099260
[TBL] [Abstract][Full Text] [Related]
9. Topical bupivacaine and proparacaine: a comparison of toxicity, onset of action, and duration of action.
Liu JC; Steinemann TL; McDonald MB; Thompson HW; Beuerman RW
Cornea; 1993 May; 12(3):228-32. PubMed ID: 8500336
[TBL] [Abstract][Full Text] [Related]
10. Effect of topical anesthesia on evaluation of corneal sensitivity and intraocular pressure in rats and dogs.
Kim J; Kim NS; Lee KC; Lee HB; Kim MS; Kim HS
Vet Ophthalmol; 2013 Jan; 16(1):43-6. PubMed ID: 22519957
[TBL] [Abstract][Full Text] [Related]
11. Prolonged Duration Topical Corneal Anesthesia With the Cationic Lidocaine Derivative QX-314.
Woodruff AG; Santamaria CM; Mehta M; Pemberton GL; Cullion K; Kohane DS
Transl Vis Sci Technol; 2019 Sep; 8(5):28. PubMed ID: 31637108
[TBL] [Abstract][Full Text] [Related]
12. Effects of action of proparacaine and tetracaine topical ophthalmic formulations on corneal sensitivity in horses.
Sharrow-Reabe KL; Townsend WM
J Am Vet Med Assoc; 2012 Dec; 241(12):1645-9. PubMed ID: 23216041
[TBL] [Abstract][Full Text] [Related]
13. Prolonged Retrobulbar Local Anesthesia of the Cornea Does Not Cause Keratopathy in Mice.
Mehta M; Zhao C; Liu A; Innocent C; Kohane DS
Transl Vis Sci Technol; 2022 Jan; 11(1):33. PubMed ID: 35072700
[TBL] [Abstract][Full Text] [Related]
14. Experimental study of tetrodotoxin, a long-acting topical anesthetic.
Schwartz DM; Fields HL; Duncan KG; Duncan JL; Jones MR
Am J Ophthalmol; 1998 Apr; 125(4):481-7. PubMed ID: 9559733
[TBL] [Abstract][Full Text] [Related]
15. Effects of Regular/Dilute Proparacaine Anesthetic Eye Drops in Combination with Ophthalmic Antibiotics on Corneal Wound Healing.
Zhang E; Gupta S; Olson E; Sinha PR; Hesemann NP; Fraunfelder FW; Mohan RR
J Ocul Pharmacol Ther; 2022 Apr; 38(3):232-239. PubMed ID: 35275738
[No Abstract] [Full Text] [Related]
16. Duration of effect and effect of multiple doses of topical ophthalmic 0.5% proparacaine hydrochloride in clinically normal dogs.
Herring IP; Bobofchak MA; Landry MP; Ward DL
Am J Vet Res; 2005 Jan; 66(1):77-80. PubMed ID: 15691039
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Proparacaine, Tetracaine, and Oxybuprocaine in Corneal Sensitivity Measurement.
Dias PB; Rodrigues Parchen MDA; Wasilewski D
J Ocul Pharmacol Ther; 2024 May; 40(4):215-221. PubMed ID: 38597912
[No Abstract] [Full Text] [Related]
18. Polymer-tetrodotoxin conjugates to induce prolonged duration local anesthesia with minimal toxicity.
Zhao C; Liu A; Santamaria CM; Shomorony A; Ji T; Wei T; Gordon A; Elofsson H; Mehta M; Yang R; Kohane DS
Nat Commun; 2019 Jun; 10(1):2566. PubMed ID: 31189915
[TBL] [Abstract][Full Text] [Related]
19. Corneal anesthetic effect and ocular tolerance of 3.5% lidocaine gel in comparison with 0.5% aqueous proparacaine and 0.5% viscous tetracaine in normal canines.
Venturi F; Blocker T; Dees DD; Madsen R; Brinkis J
Vet Ophthalmol; 2017 Sep; 20(5):405-410. PubMed ID: 27981712
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of 0.5% proparacaine stored at room temperature.
Stiles J; Krohne S; Rankin A; Chang M
Vet Ophthalmol; 2001 Sep; 4(3):205-7. PubMed ID: 11722785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
